Correlation Between Monopar Therapeutics and Widgie Nickel
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Widgie Nickel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Widgie Nickel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Widgie Nickel Limited, you can compare the effects of market volatilities on Monopar Therapeutics and Widgie Nickel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Widgie Nickel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Widgie Nickel.
Diversification Opportunities for Monopar Therapeutics and Widgie Nickel
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Monopar and Widgie is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Widgie Nickel Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Widgie Nickel Limited and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Widgie Nickel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Widgie Nickel Limited has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Widgie Nickel go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Widgie Nickel
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 3.47 times less return on investment than Widgie Nickel. But when comparing it to its historical volatility, Monopar Therapeutics is 7.34 times less risky than Widgie Nickel. It trades about 0.19 of its potential returns per unit of risk. Widgie Nickel Limited is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 2.50 in Widgie Nickel Limited on October 26, 2024 and sell it today you would lose (1.28) from holding Widgie Nickel Limited or give up 51.2% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Monopar Therapeutics vs. Widgie Nickel Limited
Performance |
Timeline |
Monopar Therapeutics |
Widgie Nickel Limited |
Monopar Therapeutics and Widgie Nickel Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Monopar Therapeutics and Widgie Nickel
The main advantage of trading using opposite Monopar Therapeutics and Widgie Nickel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Widgie Nickel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Widgie Nickel will offset losses from the drop in Widgie Nickel's long position.Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Widgie Nickel vs. Mason Graphite | Widgie Nickel vs. Rockridge Resources | Widgie Nickel vs. Volt Lithium Corp | Widgie Nickel vs. Northern Graphite |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |